Back

In-silico studies of Neurocognitive and Neuropharmacological effect of Bacopa monnieri (L.)

Sangeet, S.; Khan, A.

2021-01-21 pharmacology and toxicology
10.1101/2021.01.20.427542 bioRxiv
Show abstract

Different Indian therapeutic plants have picked up consideration for their restorative properties against neurodevelopmental disorders lately. Bacopa monnieri (B. monnieri), being one of them, finds its utilization significantly in the treatment of cognition and learning. Despite the fact that it possesses such great capacity to treat neurological issues, how precisely it confers its influence is muddled. This study makes a stride towards knowing which phytochemical is significantly associated with granting B. monnieri with therapeutic properties. The docking investigation and the molecular simulation studies proposes that there is no single phytochemical included that imparts B. monnieri a significant medicinal effect. It is really the blend of dominant part of natural phytochemicals present in B. monnieri that bestows the anti-neurological activity to B. monnieri. The ADME studies shows the convergence of properties of phytochemicals of B. monnieri with that of commercially available drugs which suggests that phytochemicals of B. monnieri can used as a potential drug source to treat neurodegenerative and neurodevelopmental disorders.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.